Search research articles
Contact Us
Filters
Showing results (1-10 of 55) with videos related to
Page
of 6
Sort By:
European Heart Journal
|
November 9, 2023
Targeting anti-CXCR3 autoantibodies as potential cardioprotective therapy: promises and challenges
Wai Hong Wilson Tang
Congestive Heart Failure (Greenwich, Conn.)
|
May 26, 2011
Optimizing cardiac resynchronization therapy in advanced heart failure
Wilfried Mullens, Wai Hong Wilson Tang
Cardiology Clinics
|
April 15, 2020
Right Heart Failure and Cardiorenal Syndrome
Thida Tabucanon, Wai Hong Wilson Tang
American Heart Journal
|
July 8, 2018
Driving with the headlights on: Measuring adequate urinary sodium excretion on the road to precision diuresis
Justin L Grodin, Wai Hong Wilson Tang
Journal of Cardiovascular Pharmacology
|
March 24, 2022
Autoantibodies and Cardiomyopathy: Focus on Beta-1 Adrenergic Receptor Autoantibodies
Wai Hong Wilson Tang, Sathyamangla V Naga Prasad
American Journal of Hypertension
|
July 3, 2020
Artificial Intelligence and Hypertension: Recent Advances and Future Outlook
Thanat Chaikijurajai, Luke J Laffin, Wai Hong Wilson Tang
Heart Failure Clinics
|
March 11, 2017
Alternative Biomarkers for Combined Biology
Yong-Hyun Kim, Jennifer Kirsop, Wai Hong Wilson Tang
European Heart Journal. Acute Cardiovascular Care
|
October 8, 2022
PRO: vasodilators remain an indispensable treatment for acute heart failure
Simon Vanhentenrijk, Frederik H Verbrugge, Wai Hong Wilson Tang, et al.
Npj Drug Discovery
|
July 1, 2026
Preferential HER4 stimulation preserves neuregulin-induced improvement of myocardial function
Samuel L Murphy, Wai Hong Wilson Tang, Xiaolei Zhuang, et al.
European Heart Journal
|
March 23, 2017
Renal sodium avidity in heart failure: from pathophysiology to treatment strategies
Wilfried Mullens, Frederik Hendrik Verbrugge, Petra Nijst, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 55) with videos related to
Sort By:
Page
of 6
European Heart Journal
|
November 9, 2023
Targeting anti-CXCR3 autoantibodies as potential cardioprotective therapy: promises and challenges
Wai Hong Wilson Tang
Congestive Heart Failure (Greenwich, Conn.)
|
May 26, 2011
Optimizing cardiac resynchronization therapy in advanced heart failure
Wilfried Mullens, Wai Hong Wilson Tang
Cardiology Clinics
|
April 15, 2020
Right Heart Failure and Cardiorenal Syndrome
Thida Tabucanon, Wai Hong Wilson Tang
American Heart Journal
|
July 8, 2018
Driving with the headlights on: Measuring adequate urinary sodium excretion on the road to precision diuresis
Justin L Grodin, Wai Hong Wilson Tang
Journal of Cardiovascular Pharmacology
|
March 24, 2022
Autoantibodies and Cardiomyopathy: Focus on Beta-1 Adrenergic Receptor Autoantibodies
Wai Hong Wilson Tang, Sathyamangla V Naga Prasad
American Journal of Hypertension
|
July 3, 2020
Artificial Intelligence and Hypertension: Recent Advances and Future Outlook
Thanat Chaikijurajai, Luke J Laffin, Wai Hong Wilson Tang
Heart Failure Clinics
|
March 11, 2017
Alternative Biomarkers for Combined Biology
Yong-Hyun Kim, Jennifer Kirsop, Wai Hong Wilson Tang
European Heart Journal. Acute Cardiovascular Care
|
October 8, 2022
PRO: vasodilators remain an indispensable treatment for acute heart failure
Simon Vanhentenrijk, Frederik H Verbrugge, Wai Hong Wilson Tang, et al.
Npj Drug Discovery
|
July 1, 2026
Preferential HER4 stimulation preserves neuregulin-induced improvement of myocardial function
Samuel L Murphy, Wai Hong Wilson Tang, Xiaolei Zhuang, et al.
European Heart Journal
|
March 23, 2017
Renal sodium avidity in heart failure: from pathophysiology to treatment strategies
Wilfried Mullens, Frederik Hendrik Verbrugge, Petra Nijst, et al.
Page
of 6